Who is sponsoring NCT04561037?

NCT04561037 is sponsored by Kafrelsheikh University.

What drugs are being tested in NCT04561037?

Interventions in NCT04561037: Pulsed Electromagnetic Field therapy (PEMFT), TMJ physical therapy program.

What condition does NCT04561037 study?

NCT04561037 studies TMJ Disorder.

Is NCT04561037 still recruiting?

NCT04561037 is currently completed. Last updated 18 February 2021.

Last reviewed 2021-02-18 · How we verify

NCT04561037

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pulsed Electromagnetic Field Therapy for TMJ Dysfunction After Facial Penetrating Injury

Completed NA Last updated 18 February 2021

What this trial tests

NA trial testing Pulsed Electromagnetic Field therapy (PEMFT) in TMJ Disorder in 33 participants. Completed in 15 October 2020.

Timeline

20 October 2019

Primary endpoint
2 October 2020

15 October 2020

Quick facts

Lead sponsor	Kafrelsheikh University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	33
Start date	20 October 2019
Primary completion	2 October 2020
Estimated completion	15 October 2020
Sites	1 location across Egypt

Drugs / interventions tested

Pulsed Electromagnetic Field therapy (PEMFT)
TMJ physical therapy program

Conditions studied

TMJ Disorder — all drugs for TMJ Disorder →

Sponsor

Kafrelsheikh University

Who can join

Adults 22 to 40, any sex, with TMJ Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aiming to investigate the effect of magnetic therapy in combination with traditional physical therapy on the pain and mouth opening, after facial penetrating wound injury with no facial fractures, that treated conservatively

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kafrelsheikh University trials

Trials by the same sponsor.

NCT07585396 — Inositol in Letrozol Resistant PCOS Women · Phase 2, PHASE3 · not yet recruiting
NCT07433920 — L-PRF Versus Sticky Bone Grafting of the Jumping Gap in AI-assisted Computer-Guided Socket Shield Immediate Implantation · NA · recruiting
NCT07368348 — Evaluation of Internal Nasal Splint-Supported Free Graft Versus Nasoseptal Flap for Endoscopic Skull Base Repair in Cere · NA · recruiting
NCT07348094 — Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin · NA · recruiting
NCT07359144 — Pilates Exercises on Nonspecific Low Back Pain in Postnatal Women · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04561037 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kafrelsheikh University
Last refreshed: 18 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04561037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing